[Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
D000284:Administration, Oral; D000818:Animals; D004359:Drug Therapy, Combination; D007273:Injections, Intramuscular; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D010087:Oxides / Q000008:administration & dosage; D011144:Polyvinylpyridine N-Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D011145:Polyvinyls / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines / Q000008:administration & dosage; D051381:Rats; D012830:Silicotuberculosis / Q000188:drug therapy*
D010087:Oxides; D011145:Polyvinyls; D011725:Pyridines; D011144:Polyvinylpyridine N-Oxide; D007538:Isoniazid
Kombinirovannoe lechenie eksperimental'nogo silikotuberkuleza poli-2-vinilpiridin-N-oksidom i izoniazidom